The Federal Trade Commission says it is ratcheting up enforcement against any illegal bribes and rebate schemes that give drugs preferential formulary...
FDAs National Center for Toxicological Research announces the publication of three International Test Method Standards in Nanotechnology by the Americ...
Federal Register notice: FDA seeks comments on an information collection revision entitled Human Drug Compounding Under Sections 503A and 503B of the ...
Federal Register notice: FDA sends to OMB an information collection extension entitled Guidance on Reagents for Detection of Specific Novel Influenza ...
Sens. Dick Durbin (D-IL), chair of the Senate Judiciary Committee, ranking member Chuck Grassley (R-IA) and Thom Tillis (R-NC) introduce bipartisan le...
CDRH makes available a draft guidance on Power Morcellator containment systems clinical performance assessments.
Some 30 GOP House members call on President Biden to take steps to alleviate a shortage of intravenous contrast agents.
FDA publishes the latest update for its list of off-patent, off-exclusivity drugs for which there are no approved generics.